Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ixoten therapy in malignant lymphomas].

P Pötzi, P Aiginger, J Kühböck

    Acta Medica Austriaca
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Ixoten (trofosfamide), a cyclophosphamide derivative, demonstrated significant efficacy in treating malignant lymphomas. This chemotherapy agent achieved an 80% remission rate with manageable side effects in clinical trials.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Macrocytic anemia and thrombocytosis associated with thymoma: a case report.

    American journal of hematology·1999
    Same author

    Adjuvant tamoxifen in postmenopausal patients with breast cancer and negative axillary lymph nodes.

    European journal of cancer (Oxford, England : 1990)·1992
    Same author

    Risk factors for bilateral testicular germ cell tumors. Does heredity play a role?

    Cancer·1991
    Same author

    Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on.

    Lancet (London, England)·1990
    Same author

    Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.

    British journal of cancer·1989
    Same author

    [Simultaneous radiation- and chemotherapy (methotrexate and bleomycin) of inoperable malignant oro-facial tumors].

    Fogorvosi szemle·1989

    Area of Science:

    • Oncology
    • Pharmacology